These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37144752)

  • 21. Bactericidal activities and action mechanism of the novel antimicrobial peptide Hylin a1 and its analog peptides against Acinetobacter baumannii infection.
    Park HJ; Kang HK; Park E; Kim MK; Park Y
    Eur J Pharm Sci; 2022 Aug; 175():106205. PubMed ID: 35561952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.
    Lin MF; Tsai PW; Chen JY; Lin YY; Lan CY
    PLoS One; 2015; 10(10):e0141107. PubMed ID: 26484669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic Activity of Ceragenins Against Carbapenem-Resistant Acinetobacter baumannii Strains in Both Checkerboard and Dynamic Time-Kill Assays.
    Bozkurt-Guzel C; Inci G; Oyardi O; Savage PB
    Curr Microbiol; 2020 Aug; 77(8):1419-1428. PubMed ID: 32189050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AbAMPdb: a database of Acinetobacter baumannii specific antimicrobial peptides.
    Anwer F; Navid A; Faiz F; Haider U; Nasir S; Farooq M; Zahra M; Bano A; Bashir HH; Ahmad M; Abbas SA; Room SE; Saeed MT; Ali A
    Database (Oxford); 2024 Oct; 2024():. PubMed ID: 39395188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bovine myeloid antimicrobial peptide (BMAP-28) and its analogs kill pan-drug-resistant Acinetobacter baumannii by interacting with outer membrane protein A (OmpA).
    Guo Y; Xun M; Han J
    Medicine (Baltimore); 2018 Oct; 97(42):e12832. PubMed ID: 30334982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.
    Liu CB; Shan B; Bai HM; Tang J; Yan LZ; Ma YB
    Dongwuxue Yanjiu; 2015 Jan; 36(1):41-7. PubMed ID: 25730460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
    Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
    Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Responses of Multidrug-Resistant
    Liu C; Shan B; Qi J; Ma Y
    Front Cell Infect Microbiol; 2017; 7():466. PubMed ID: 29164074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations.
    Skariyachan S; Muddebihalkar AG; Badrinath V; Umashankar B; Eram D; Uttarkar A; Niranjan V
    Infect Genet Evol; 2020 Aug; 82():104314. PubMed ID: 32268193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains.
    Gopal R; Kim YG; Lee JH; Lee SK; Chae JD; Son BK; Seo CH; Park Y
    Antimicrob Agents Chemother; 2014; 58(3):1622-9. PubMed ID: 24366740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-lactam resistance and the effectiveness of antimicrobial peptides against KPC-producing bacteria.
    da Costa de Souza G; Roque-Borda CA; Pavan FR
    Drug Dev Res; 2022 Nov; 83(7):1534-1554. PubMed ID: 36042694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.
    Jha RK; Khan RJ; Amera GM; Singh E; Pathak A; Jain M; Muthukumaran J; Singh AK
    J Mol Model; 2020 Oct; 26(11):304. PubMed ID: 33068184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acinetobacter baumannii: Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline.
    Dehbanipour R; Ghalavand Z
    J Clin Pharm Ther; 2022 Nov; 47(11):1875-1884. PubMed ID: 36200470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii.
    Mant CT; Jiang Z; Gera L; Davis T; Nelson KL; Bevers S; Hodges RS
    J Med Chem; 2019 Apr; 62(7):3354-3366. PubMed ID: 30848594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Iron regulated outer membrane proteins (IROMPs) as potential targets against carbapenem-resistant Acinetobacter spp. isolated from a Medical Centre in Malaysia.
    Hwa WE; Subramaniam G; Mansor MB; Yan OS; ; Anbazhagan D; Devi SS
    Indian J Med Res; 2010 Apr; 131():578-83. PubMed ID: 20424311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia.
    Jung CJ; Liao YD; Hsu CC; Huang TY; Chuang YC; Chen JW; Kuo YM; Chia JS
    Sci Rep; 2021 Apr; 11(1):7318. PubMed ID: 33795739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii.
    Amera GM; Khan RJ; Pathak A; Jha RK; Jain M; Muthukumaran J; Singh AK
    J Mol Graph Model; 2020 Nov; 100():107675. PubMed ID: 32731183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.